Allergic Reaction Management with Antihistamines

Introduction to Antihistamine Therapy

The American Academy of Allergy, Asthma, and Immunology recommends avoiding first-generation antihistamines like doxylamine and chlorpheniramine for allergic reactions due to significant risks of sedation, cognitive impairment, and anticholinergic effects, instead preferring second-generation antihistamines 1, 2

First-generation antihistamines cause significant daytime drowsiness and performance impairment, increasing the risk of fatal automobile accidents and occupational accidents by 1.5-fold 2
The sedative effects of first-generation antihistamines persist beyond plasma levels of the parent compound, causing next-day impairment even with bedtime dosing 1, 2
Older adults are particularly vulnerable to psychomotor impairment from first-generation antihistamines, with increased risk of falls, fractures, and subdural hematomas 1, 2

Both doxylamine and chlorpheniramine cause problematic anticholinergic effects including dry mouth and eyes, constipation, urinary retention, and increased risk of narrow-angle glaucoma 1, 2
Elderly patients with comorbidities face amplified risks from the anticholinergic properties of first-generation antihistamines 1, 2

For allergic rhinitis, second-generation antihistamines like fexofenadine, loratadine, and desloratadine are strongly preferred due to their lack of sedation at recommended doses 1, 6
In anaphylaxis, epinephrine is the first-line treatment, and if an adjunctive antihistamine is needed, diphenhydramine 25-50 mg IV/oral or cetirizine 10 mg may be considered 4, 5

Neither doxylamine nor chlorpheniramine should be first-line for allergic reactions; if a first-generation antihistamine is used in anaphylaxis as adjunctive therapy, diphenhydramine 25-50 mg is the standard choice, not doxylamine or chlorpheniramine 4, 5
Bedtime dosing of first-generation antihistamines might be considered when a soporific effect is specifically desired and anticholinergic properties may benefit persistent rhinorrhea, though intranasal anticholinergics are preferred over systemic agents 1, 2, 6